代表性论文（*，第一；#，通讯）
1. Xia Zhang, Peng Peng, Li-Wei Bao, An-Qi Zhang, Bo Yu, Tao Li, Jing Lei, Hui-Hui Zhang#andShang-Ze Li#(2024) Ubiquitin-Specific Protease 1 Promotes Bladder Cancer Progression by Stabilizing c-MYC,Cells
2.Li, S. Z.*, Shu, Q. P.*, Zhou, H. M., Liu, Y. Y., Fan, M. Q., Liang, X. Y., Qi, L. Z., He, Y. N., Liu, X. Y., Du, X. H., Huang, X. C., Chen, Y. Z., Du, R. L., Liang, Y. X. & Zhang, X. D. (2024) CLK2 mediates IkappaBalpha-independent early termination of NF-kappaB activation by inducing cytoplasmic redistribution and degradation,Nat Commun.15, 3901. (Nature Index)
3. Yang, S., Hu, C., Chen, X., Tang, Y., Li, J., Yang, H., Yang, Y., Ying, B., Xiao, X.,Li, S. Z.#, Gu, L. & Zhu, Y. (2024) Crosstalk between metabolism and cell death in tumorigenesis,Mol Cancer.23, 71.
4.Ren, J., Mo, Z., Huang, Z. &Li, S.#(2024) Hedyotis diffusa Willd and Astragalus membranaceus May Exert Anti-colon Cancer Effects by Affecting AKTI Expression, as Determined by Network Pharmacology and Molecular Docking,Curr Comput Aided Drug Des.
5. Zhang, H. H., Zhang, A. Q., Peng, P., Huang, L., Liu, C. Y., Nie, X. R., Hou, D. F., Zhang, X. &Li, S. Z.#(2024) USP5 facilitates bladder cancer progression by stabilizing the c-Jun protein,Cancer Cell Int.24, 32.
6. Liu, T., Fan, M. Q., Xie, X. X., Shu, Q. P., Du, X. H., Qi, L. Z., Zhang, X. D., Zhang, M. H., Shan, G., Du, R. L. &Li, S. Z.#(2023) Activation of CTNNB1 by deubiquitinase UCHL3-mediated stabilization facilitates bladder cancer progression,J Transl Med.21, 656.
7. Du, X. H., Ke, S. B., Liang, X. Y., Gao, J., Xie, X. X., Qi, L. Z., Liu, X. Y., Xu, G. Y., Zhang, X. D., Du, R. L. &Li, S. Z.#(2023) USP14 promotes colorectal cancer progression by targeting JNK for stabilization,Cell Death Dis. 14, 56.
8. Zhang, J., Hu, C., Xie, X., Qi, L., Li, C. &Li, S.#(2023) Immune Checkpoint Inhibitors in HBV-Caused Hepatocellular Carcinoma Therapy,Vaccines(Basel). 11(3): 614.
9.Li, S. Z.*, Zhang, Z. Y.*, Chen, J.*, Dong, M. Y., Du, X. H., Gao, J., Shu, Q. P., Li, C., Liang, X. Y., Ding, Z. H., Du, R. L., Wang, J. & Zhang, X. D. (2022) NLK is required for Ras/ERK/SRF/ELK signaling to tune skeletal muscle development by phosphorylating SRF and antagonizing the SRF/MKL pathway,Cell Death Discov.8, 4.
10. Tao, H., Liao, Y., Yan, Y., He, Z., Zhou, J., Wang, X., Peng, J.,Li, S.#& Liu, T.#(2021) BRCC3 Promotes Tumorigenesis of Bladder Cancer by Activating the NF-kappaB Signaling Pathway Through Targeting TRAF2,Front Cell Dev Biol.9, 720349.
11. Zhang, H. H., Li, C., Ren, J. W., Liu, L., Du, X. H., Gao, J., Liu, T.#&Li, S. Z.#(2021) OTUB1 facilitates bladder cancer progression by stabilizing ATF6 in response to endoplasmic reticulum stress,Cancer Sci. 112, 2199-2209.
12. Li, C.*,Li, S. Z.*, Huang, X. C., Chen, J., Liu, W., Zhang, X. D., Song, X. M. & Du, R. L. (2021) PTPN18 promotes colorectal cancer progression by regulating the c-MYC-CDK4 axis,Genes Dis.8, 838-848.
13.Zhang, M. H., Zhang, H. H., Du, X. H., Gao, J., Li, C., Shi, H. R. &Li, S. Z.#(2020) UCHL3 promotes ovarian cancer progression by stabilizing TRAF2 to activate the NF-kappaB pathway,Oncogene.39, 322-333.
14.Li, S. Z.*,#, Shu, Q. P.*, Song, Y., Zhang, H. H., Liu, Y., Jin, B. X., Liuyu, T. Z., Li, C., Huang, X. C., Du, R. L., Song, W., Zhong, B. & Zhang, X. D.#(2019) Phosphorylation of MAVS/VISA by Nemo-like kinase (NLK) fordegradation regulates the antiviral innate immune response,Nat Commun.10, 3233. (Nature Index)
15.Li, S.*, Fong, K. W.*, Gritsina, G., Zhang, A., Zhao, J. C., Kim, J., Sharp, A., Yuan, W., Aversa, C., Yang, X. J., Nelson, P. S., Feng, F. Y., Chinnaiyan, A. M., de Bono, J. S., Morrissey, C., Rettig, M. B. & Yu, J. (2019) Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer,Cancer Res.79, 2580-2592. (Cover letter，Nature Index)
16. Zhao, H., Pan, W. M., Zhang, H. H., Song, Y., Chen, J., Xiang, Y., Gu, B.,Li, S. Z.#, Du, R. L. & Zhang, X. D.#(2019) Cancer testis antigen 55 deficiency attenuates colitis-associated colorectal cancer by inhibiting NF-kappaB signaling,Cell Death Dis.10, 304.(IF: 8.869，中科院一区/Top期刊)ISSN：2041-4889
17.Li, S.*,#, Hu, L.*, Li, J., Zhu, J., Zeng, F., Huang, Q., Qiu, L., Du, R. & Cao, R. (2019) Design, synthesis, structure-activity relationships and mechanism of action of new quinoline derivatives as potential antitumor agents,Eur J Med Chem.162, 666-678.
18.Li, S. Z.*,#, Ren, J. W.*, Fei, J., Zhang, X. D. & Du, R. L. (2019) Cordycepin induces Baxdependent apoptosis in colorectal cancer cells,Mol Med Rep.19, 901-908.
19.Li, S. Z.*, Zeng, F.*, Li, J., Shu, Q. P., Zhang, H. H., Xu, J., Ren, J. W., Zhang, X. D., Song, X. M. & Du, R. L. (2018) Nemo-like kinase (NLK) primes colorectal cancer progression by releasing the E2F1 complex from HDAC1,Cancer Lett.431, 43-53.
20. Zhang, H. H.*,Li, S. Z.*, Zhang, Z. Y., Hu, X. M., Hou, P. N., Gao, L., Du, R. L. & Zhang, X. D. (2014) Nemo-like kinase is critical for p53 stabilization and function in response to DNA damage,Cell Death Differ.21, 1656-63.
21.Li, S. Z.*, Zhang, H. H.*, Liang, J. B., Song, Y., Jin, B. X., Xing, N. N., Fan, G. C., Du, R. L. & Zhang, X. D. (2014) Nemo-like kinase (NLK) negatively regulates NF-kappa B activity through disrupting the interaction of TAK1 with IKKbeta,Biochim Biophys Acta.1843, 1365-72.
22.Li, S. Z.*, Song, Y.*, Zhang, H. H., Jin, B. X., Liu, Y., Liu, W. B., Zhang, X. D. & Du, R. L. (2014) UbcH10 overexpression increases carcinogenesis and blocks ALLN susceptibility in colorectal cancer,Sci Rep.4, 6910.
23.Li, S. Z.*, Zhang, H. H.*, Zhang, J. N., Zhang, Z. Y., Zhang, X. F., Zhang, X. D. & Du, R. L. (2013) ALLN hinders HCT116 tumor growth through Bax-dependent apoptosis,Biochem Biophys Res Commun.437, 325-30.
24.Liu, Y.,Li, S., Zhang, H., Wan, Z., Zhang, X. & Du, R. (2012) A one-step cloning method for the construction of somatic cell gene targeting vectors: application to production of human knockout cell lines,BMC Biotechnol.12, 71.
